- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01835444
A Multicenter Research on the Effects of Substitution of Hospital Ward Care From Medical Doctors to Physician Assistants
Worthy Assistants: Does Substituting Hospital Ward Care From Medical Residents to Physician Assistants Result in Cost Savings?
Reallocation of healthcare is one solution to the problems healthcare is facing. In the Netherlands reallocation of care to Physician Assistants (PAs) hasn't adequately been studied. Given the growing number of PAs, it is essential to evaluate the effectiveness and efficacy of (Dutch) PA services.
This multicenter matched-controlled study aims to evaluate the (cost) effectiveness of substitution of hospital ward care from medical doctors (MDs) to PAs. The traditional model in which the role of house officer is taken by medical doctors MD model) will be compared with a mixed model in which a PA functions as house officer together with a medical doctor (PA/MD model). Hospital wards will be matched on medical specialism and hospital type (i.e. academic;non-academic). On the basis of USA studies, it is hypothesized that the mixed PA/MD model compared to the MD model reduces the costs of healthcare, while improving or maintaining the clinical outcomes, patients and provider satisfaction, and continuity and quality of care.
Primary research question:
• What is the effect of 'mixed PA/MD model' compared with 'MD model' on efficiency of care?
Secondary research questions:
- What is the effect of 'mixed PA/MD model' compared with 'MD model' on clinical and patients outcomes?
- What is the effect of 'mixed PA/MD model' compared with 'MD model' on continuity of care?
- What is the effect of 'mixed PA/MD model' compared with 'MD model' on nurses and (specialist) medicals doctor experiences?
- What are the barriers and facilitating factors considering the implementation of PAs as house officer?
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Utrecht, Netherlands
- UMC Utrecht
-
-
Drenthe
-
Emmen, Drenthe, Netherlands
- Scheper Ziekenhuis
-
-
Friesland
-
Heerenveen, Friesland, Netherlands, 8441 PW
- Tjongerschans Ziekenhuis
-
-
Gelderland
-
Apeldoorn, Gelderland, Netherlands
- Gelre Ziekenhuizen
-
Arnhem, Gelderland, Netherlands, 6800 TA
- Rijnstate
-
Doetinchem, Gelderland, Netherlands
- Slingeland Ziekenhuis
-
Ede, Gelderland, Netherlands
- Ziekenhuis de Gelderse Vallei
-
Nijmegen, Gelderland, Netherlands, 6500HB
- Radboud University Nijmegen Medical Centre
-
Nijmegen, Gelderland, Netherlands, 6532 SZ
- Canisius Wilhelmina Ziekenhuis
-
Winterswijk, Gelderland, Netherlands
- Streekziekenhuis Koningin Beatrix
-
-
Limburg
-
Roermond, Limburg, Netherlands, 6043 CV
- Laurentius Ziekenhuis
-
Roermond, Limburg, Netherlands
- Laurentius Ziekenhuis
-
Sittard, Limburg, Netherlands
- Orbis Medisch Centrum
-
Venlo, Limburg, Netherlands, 5912 BL
- VieCuri Medical Center
-
-
Noord-Brabant
-
Bergen op Zoom, Noord-Brabant, Netherlands, 4624 VT
- Lievensberg ziekenhuis
-
Den Bosch, Noord-Brabant, Netherlands
- Jeroen Bosch Ziekenhuis
-
Helmond, Noord-Brabant, Netherlands
- Elkerliek Ziekenhuis
-
Roosendaal, Noord-Brabant, Netherlands, 4708 AE
- Fransiscus Ziekenhuis
-
Tilburg, Noord-Brabant, Netherlands
- St. Elisabeth Ziekenhuis
-
Tilburg, Noord-Brabant, Netherlands
- TweeSteden Ziekenhuis
-
-
Zeeland
-
Dirksland, Zeeland, Netherlands
- Van Weel Bethesda Ziekenhuis
-
-
Zuid-Holland
-
Delft, Zuid-Holland, Netherlands
- Reinier de Graaf Gasthuis
-
Den Haag, Zuid-Holland, Netherlands
- Hagaziekenhuis
-
Den Haag, Zuid-Holland, Netherlands
- Medisch Centrum Haaglanden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
• Wards using a mixed PA/physician model (with PA ward coverage of at least 50% of the available ward hours per week, during dayshifts on weekdays) or a physician model (daily coverage by a (specialized medical doctor)
Exclusion criteria on ward level:
- Wards from specialty hospitals
- Wards with only PAs in training
- Wards with a nurse practitioner (NP) in the role of house officer (NP, NP/MD or PA/NP/MD model)
- Pediatric and psychiatric wards, intensive care units
Exclusion criteria on patient level:
- Terminal patients
- Not fluent in Dutch language
- Age < 18 years
- Patients in daycare
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
MD model
Hospital wards at which ward care is provided only by Medical Doctors (MDs)
|
|
|
PA/MD model
Hospital wards at which ward care is provided by both Physician Assistants (PAs) and Medical Doctors (MDs)
|
Intervention wards are hospital wards at which ward care is provided by both Physician Assistants (PAs) and Medical Doctors (MDs)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of hospital stay
Time Frame: Patients will be followed for the duration of hospital stay; an expected average of 6 days
|
The difference between date of discharge and date of admission
|
Patients will be followed for the duration of hospital stay; an expected average of 6 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficiency of care
Time Frame: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
|
Relevant costs associated with the principal admission (length of hospital stay, resource use, consultation of health care suppliers, salaries) and costs that occurred after discharge (unplanned readmission, presentation at emergency departments, visits of general practitioner, required home care) will be calculated, considering a follow-up period from admission until 1 month after discharge.
All volumes will be collected in detail at an individual patient level, primarily from medical patient records and patient and care provider questionnaires.
Medical costs will be calculated by multiplying the volumes of healthcare use with corresponding unit prices, derived from the Dutch Manual for Costing Research
|
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
|
|
Quality of hospital ward care
Time Frame: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
|
To estimate the quality of ward care, a set of objective indicators has been developed through literature review and clinical input from a physician panel.
We have selected both clinical indicators and process indicators, with a follow-up period of maximum 1 month after discharge.
Clinical indicators were based on the national set of indicators for quality of hospital care from the Dutch Health Care Inspectorate (IGZ) and consider the incidences of inhospital mortality, cardiopulmonary resuscitation, unplanned readmission, presentation at emergency department after discharge,unplanned transfer to Intensive Care Unit, development of hospital infections, pressure sore and fever, and pain scores .
Process indicators are the number of days between a patients discharge and the date of written turnover to general practitioner or other hospital, and acquaintance with the patient within 24 hours after admission
|
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
|
|
Patient quality of life
Time Frame: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days. Measurements of quality of life will be performed at hospital admission, hospital discharge and 1 month after discharge
|
Patient experienced quality of life will be measured by the EQ-5D questionnaire.
This questionnaire will be distributed at hospital admission, hospital discharge, and 1 month after discharge
|
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days. Measurements of quality of life will be performed at hospital admission, hospital discharge and 1 month after discharge
|
|
Feasibility, barriers and facilitators
Time Frame: 12 months
|
Semi-structured (group)interviews will be held with PAs, (specialized) medical doctors, ward nurses and heads of the departments.
The interviews will cover experiences with the utilized ward model, communication between professionals, satisfaction, and barriers and facilitators related to the utilization of the 'mixed PA/MD model'.
Specific attention will be paid to the role and functioning of PAs
|
12 months
|
|
Care provider experiences
Time Frame: 12 months
|
Job satisfaction, subjective workload and stress reaction of PAs, (specialized) medical doctors and ward nurses will be measured by a self-administered questionnaire. Job satisfaction will be measured by an adapted version of the job satisfaction questionnaire of McCranie, stress reaction will be measured by a short version of the General Health Questionnaire (GHQ-12) Objective workload will be measured by calculating the ratio between number of working hours at the hospital ward, and the number of patients the PA or medical doctor is responsible for. |
12 months
|
|
Continuity of care
Time Frame: 4 months
|
Continuity of care will be measured by deriving the number of rotations of PAs and medical doctors at the hospital ward from work schedules, which will be assessed during 4 weeks, spread over 4 months
|
4 months
|
|
Patient experiences with hospital ward care
Time Frame: Patients will be followed for the duration of hospital stay; an expected average of 6 days. Measurement of patient experiences will be performed at discharge
|
Patient experiences with medical ward care will be assessed by a self-administered questionnaire at discharge.
This questionnaire focuses on satisfaction with communication, experienced continuity of care and cooperation, and the patients view on the medical competencies of the ward care provider
|
Patients will be followed for the duration of hospital stay; an expected average of 6 days. Measurement of patient experiences will be performed at discharge
|
Collaborators and Investigators
Investigators
- Principal Investigator: M.G.H. Laurant, PhD, IQ healthcare, UMC St Radboud
Publications and helpful links
General Publications
- Timmermans MJC, van Vught AJAH, Peters YAS, Meermans G, Peute JGM, Postma CT, Smit PC, Verdaasdonk E, de Vries Reilingh TS, Wensing M, Laurant MGH. The impact of the implementation of physician assistants in inpatient care: A multicenter matched-controlled study. PLoS One. 2017 Aug 9;12(8):e0178212. doi: 10.1371/journal.pone.0178212. eCollection 2017.
- Timmermans MJC, van den Brink GT, van Vught AJAH, Adang E, van Berlo CLH, Boxtel KV, Braunius WW, Janssen L, Venema A, van den Wildenberg FJ, Wensing M, Laurant MGH. The involvement of physician assistants in inpatient care in hospitals in the Netherlands: a cost-effectiveness analysis. BMJ Open. 2017 Jul 10;7(7):e016405. doi: 10.1136/bmjopen-2017-016405.
- Timmermans MJ, van Vught AJ, Van den Berg M, Ponfoort ED, Riemens F, van Unen J, Wobbes T, Wensing M, Laurant MG. Physician assistants in medical ward care: a descriptive study of the situation in the Netherlands. J Eval Clin Pract. 2016 Jun;22(3):395-402. doi: 10.1111/jep.12499. Epub 2015 Dec 23.
- Timmermans MJ, van Vught AJ, Wensing M, Laurant MG. The effectiveness of substitution of hospital ward care from medical doctors to physician assistants: a study protocol. BMC Health Serv Res. 2014 Jan 28;14:43. doi: 10.1186/1472-6963-14-43. Erratum In: BMC Health Serv Res. 2016;16(1):115.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 80-82310-97-12094
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substitution of Care
-
Mundipharma Research LimitedCompleted
-
Michelle Hurst, PhDEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedProportional Reasoning | Substitution HeuristicUnited States
-
Sheba Medical CenterUnknown
-
University Hospital, AngersUnknown
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA); Clemson UniversityCompletedStandard of Care | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RCUnited States
-
University of ChicagoPatient-Centered Outcomes Research InstituteRecruitingComprehensive Care | Quality of Care | Medicare | Cost of CareUnited States
-
MetroHealth Medical CenterCompleted
-
Northwestern UniversityCompletedContinuity of Patient Care | Patient-Centered Care | High Utilizers of Hospital CareUnited States
-
Hôpital NOVOActive, not recruitingPalliative Care | End of Life Care | Terminal CareFrance
-
University of AlbertaUniversity of CalgaryCompletedAdvance Care Planning | Goals of CareCanada
Clinical Trials on PA/MD model
-
University of the Balearic IslandsFundació La Marató de TV3UnknownNon Alcoholic Fatty Liver DiseaseSpain
-
Azura OphthalmicsSyneos Health; Cliantha ResearchCompletedDry Eye | Meibomian Gland DysfunctionCanada, Australia, New Zealand
-
Azura OphthalmicsORA, Inc.Active, not recruitingDry Eye DiseaseUnited States
-
University of MilanUniversity of Florence; University of TeramoNot yet recruiting
-
Azura OphthalmicsAvaniaCompletedMeibomian Gland DysfunctionAustralia, New Zealand
-
Addpharma Inc.RecruitingMixed DyslipidemiaKorea, Republic of
-
Erasme University HospitalFonds de la Recherche Scientifique (fnrs)Not yet recruiting
-
Azura OphthalmicsThe University of New South WalesCompletedMeibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)Australia
-
Ironwood Pharmaceuticals, Inc.CompletedHypercholesterolemiaUnited States
-
Eun-ji KimCompletedSkin LesionKorea, Republic of